Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Research

• Publication date

  2011-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-10-3185PMID 21123450PMCID PMC3140407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways

  2010influential reference
• Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence

  2010cited by this paper
• Glyceollin I, a Novel Antiestrogenic Phytoalexin Isolated from Activated Soy

  2010cited by this paper
• Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.

  2009influential reference
• Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP

  2009cited by this paper
• CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro.

  2009cited by this paper
• Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.

  2009cited by this paper
• Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.

  2009cited by this paper
• Challenges in defining predictive markers for response to endocrine therapy in breast cancer.

  2009cited by this paper
• Biological determinants of endocrine resistance in breast cancer

  2009cited by this paper
• CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK

  2009cited by this paper
• A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.

  2009cited by this paper
• Regulation of cell-cell adhesion by the cadherin-catenin complex.

  2008cited by this paper
• Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas

  2008cited by this paper
• 17β-Estradiol Promotes Breast Cancer Cell Proliferation-Inducing Stromal Cell-Derived Factor-1-Mediated Epidermal Growth Factor Receptor Transactivation: Reversal by Gefitinib Pretreatment

  2008cited by this paper
• Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)

  2008cited by this paper
• Akt plays an important role in breast cancer cell chemotaxis to CXCL12

  2008cited by this paper
• SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway.

  2008cited by this paper
• CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.

  2007cited by this paper
• The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.

  2007cited by this paper
• Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling.

  2007cited by this paper
• Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.

  2006influential reference
• Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type

  2006cited by this paper
• Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.

  2006cited by this paper
• The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study

  2006cited by this paper
• Antiestrogenic Glyceollins Suppress Human Breast and Ovarian Carcinoma Tumorigenesis

  2006cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• The role of cell adhesion molecules in cancer invasion and metastasis

  2005cited by this paper
• Review: chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer

  2005cited by this paper
• The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells

  2004cited by this paper
• CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer

  2004cited by this paper
• Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.

  2004cited by this paper
• Estrogen receptor phosphorylation.

  2003cited by this paper
• Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma

  2003cited by this paper
• Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling

  2003cited by this paper
• β-Arrestin2 Is Critically Involved in CXCR4-mediated Chemotaxis, and This Is Mediated by Its Enhancement of p38 MAPK Activation*

  2002cited by this paper
• Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.

  2002influential reference
• Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.

  2001cited by this paper
• Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α

  2001cited by this paper
• Phosphorylation of ERK1/2 mitogen‐activated protein kinase is associated with poor response to anti‐hormonal therapy and decreased patient survival in clinical breast cancer

  2001influential reference
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods.

  2000cited by this paper
• Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.

  1998cited by this paper
• Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

  1997cited by this paper
• IMMUNOHISTOCHEMICAL ASSAY FOR OESTROGEN RECEPTORS IN PARAFFIN WAX SECTIONS OF BREAST CARCINOMA USING A NEW MONOCLONAL ANTIBODY

  1996cited by this paper
• Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.

  1996cited by this paper
• Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

  1995cited by this paper
• MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors.

  1993cited by this paper
• Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding.

  1992cited by this paper
• Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells.

  1992influential reference
• Valeur pronostique des micrométastases ganglionnaires détectées par analyse immunohistochimique. A propos de 168 cas de carcinomes mammaires suivis pendant plus de 10 ans.

  1991cited by this paper
• [Prognostic value of lympho node micrometastases detected by immunohistochemistry. Study of 168 cases of breast cancer with a 10-year follow-up].

  1991cited by this paper
• Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.

  1989cited by this paper
• Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice.

  1959cited by this paper

• CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer

  2025cites this paper
• A combined study of network-based prediction and in vitro experimental validation on the procarcinogenic mechanism of propylparaben in estrogen receptor-positive breast cancer cells.

  2025cites this paper
• CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy

  2025cites this paper
• CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma.

  2025cites this paper
• Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases

  2025cites this paper
• Comprehensive characterization of high-risk coding and non-coding single nucleotide polymorphisms of human CXCR4 gene

  2024cites this paper
• Roles of Chemokine Axes in Breast Cancer.

  2024cites this paper
• The role of SIK3 in HER2+ gastric cancer cells

  2024cites this paper
• Genes Related to Motility in an Ionizing Radiation and Estrogen Breast Cancer Model

  2024cites this paper
• TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistance.

  2023cites this paper
• Potential therapeutic role for pigment epithelium-derived factor in post-menopausal breast cancer bone metastasis.

  2023cites this paper
• Recent advances in therapeutic strategies for triple-negative breast cancer

  2022cites this paper
• Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer

  2022cites this paper
• NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells

  2021cites this paper
• Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives

  2021cites this paper
• Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer

  2021cites this paper
• Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells

  2021cites this paper
• At the Bench: Pre‐clinical evidence for multiple functions of CXCR4 in cancer

  2020cites this paper
• Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy

  2020cites this paper
• Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review).

  2020cites this paper
• Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy.

  2020cites this paper
• The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis

  2020cites this paper
• Role of the CXCR4-LASP1 Axis in the Stabilization of Snail1 in Triple-Negative Breast Cancer

  2020cites this paper
• RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression

  2020cites this paper
• Prognostic Value of CXCR2 in Breast Cancer

  2020cites this paper
• CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation

  2020influential citation
• Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer

  2019cites this paper
• Involvement of CXCR4 in Normal and Abnormal Development

  2019cites this paper
• CXCR4 antagonism in combination with IDO1 inhibition weakens immune suppression and inhibits tumor growth in mouse breast cancer bone metastases

  2019cites this paper
• Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.

  2019cites this paper
• CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members

  2019cites this paper
• CXCR4 antagonism in combination with IDO1 inhibition weakens immune suppression and inhibits tumor growth in mouse breast cancer bone metastases

  2019influential citation
• Promise of chemokine network-targeted nanoparticles in combination nucleic acid therapies of metastatic cancer.

  2019cites this paper
• CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic review

  2019cites this paper
• Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients

  2018cites this paper
• CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression

  2018cites this paper
• Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma

  2018influential citation
• Examination of methylation changes of VIM, CXCR4, DOK7, and SPDEF genes in peripheral blood DNA in breast cancer patients.

  2018cites this paper
• Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy

  2018cites this paper
• Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.

  2018cites this paper
• Cytokine‐mediated therapeutic resistance in breast cancer

  2018cites this paper
• Nuclear Respiratory Factor 1 Acting as an Oncoprotein Drives Estrogen-Induced Breast Carcinogenesis

  2018cites this paper
• Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells.

  2018cites this paper
• NRF1-Mediated Oncogenic Reprogramming Drives Estrogen-Induced Breast Carcinogenesis

  2018cites this paper
• PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

  2018cites this paper
• Delivery of MicroRNA with CXCR4-Targeted Nanoparticles in Metastatic Cancer Treatment

  2018cites this paper
• CCL 20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture † Running title : CCL 20 effects in breast cancer cells

  2017cites this paper
• Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms

  2017cites this paper
• UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor

  2017cites this paper
• Early changes in the apparent diffusion coefficient and MMP-9 expression of a cervical carcinoma U14 allograft model following irradiation.

  2017cites this paper
• Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and in-silico expression analysis of CXCL12–CXCR4 associated biological regulatory network

  2017cites this paper
• Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness

  2017cites this paper
• Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer

  2017cites this paper
• CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture

  2017cites this paper
• Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors

  2017cites this paper
• Adenosine arrests breast cancer cell motility by A3 receptor stimulation

  2016cites this paper
• Fat grafting for breast cancer patients: From basic science to clinical studies.

  2016cites this paper
• The analysis of estrogen receptor-α positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI-9: Possible regulatory mechanisms.

  2016cites this paper
• Tumour promoting HER2 splice variant Δ16HER2: Regulation and implication in breast cancer

  2016cites this paper
• Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis

  2016cites this paper
• Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway

  2016cites this paper
• The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells

  2016cites this paper
• A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts

  2016cites this paper
• G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis

  2016cites this paper
• Paracrine CCL20 loop induces epithelial‐mesenchymal transition in breast epithelial cells

  2016cites this paper
• Modulation of Low Pathogenic Avian Influenza Using Attenuated Salmonella Vaccine Chicken Interferon-α and Interleukin-18

  2016cites this paper
• Erratum to: CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis

  2016cites this paper
• Identification of novel 2-(1H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth and motility.

  2016cites this paper
• Laser Direct‐Write Onto Live Tissues: A Novel Model for Studying Cancer Cell Migration

  2016cites this paper
• Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer

  2015cites this paper
• Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures

  2015cites this paper
• The Intricate Role of CXCR 4 in Cancer

  2015cites this paper
• The impact of tumor stroma on drug response in breast cancer.

  2015cites this paper
• Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer

  2015cites this paper
• Mechanisms of aromatase inhibitor resistance

  2015cites this paper
• Microenvironment and endocrine resistance in breast cancer: Friend or foe?

  2015cites this paper
• GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells

  2015cites this paper
• Implications of CXCR4/CXCL12 Interaction for Cancer Stem Cell Maintenance and Cancer Progression

  2015cites this paper
• CXCR 4 Protein Epitope Mimetic Antagonist POL 5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer

  2015cites this paper
• Expression and regulation of the ABC transporters in tumour cells

  2015cites this paper
• Positron Emission Tomographic Imaging of CXCR4 in Cancer: Challenges and Promises

  2015cites this paper
• CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer

  2015cites this paper
• Extracts from Curcuma zedoaria Inhibit Proliferation of Human Breast Cancer Cell MDA-MB-231 In Vitro

  2014cites this paper
• CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways

  2014cites this paper
• The wound healing, chronic fibrosis, and cancer progression triad.

  2014cites this paper
• Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.

  2014cites this paper
• The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.

  2014cites this paper
• Constitutively active chemokine CXC receptors.

  2014cites this paper
• Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor.

  2014cites this paper
• Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells

  2014cites this paper
• The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets

  2014cites this paper
• High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases

  2014cites this paper
• Ectopic MicroRNA-150-5p Transcription Sensitizes Glucocorticoid Therapy Response in MM1S Multiple Myeloma Cells but Fails to Overcome Hormone Therapy Resistance in MM1R Cells

  2014cites this paper
• Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer

  2014cites this paper
• Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers

  2014cites this paper
• Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer

  2014cites this paper
• Examination of Structure–Activity Relationship of Viologen-Based Dendrimers as CXCR4 Antagonists and Gene Carriers

  2014cites this paper
• The intricate role of CXCR4 in cancer.

  2014cites this paper
• Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.

  2014cites this paper
• A novel approach for enriching cancer stem cells from the human SW-13 adrenocortical carcinoma cell line.

  2014cites this paper